Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0758
D

Failure to Document Specific Conditions for Psychotropic Medications

Cheswick, Pennsylvania Survey Completed on 03-14-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to dispose of or reconcile discontinued medications in a timely manner in the Third Floor Medication Room, as confirmed by Employee E5. This action is in violation of the Pennsylvania Code 211.12 (d)(3)(5) regarding nursing services and 211.9 (a)(1)(j.1)(k) concerning pharmacy services. Additionally, the facility did not meet the requirements outlined in §483.45(e) regarding the administration of psychotropic drugs. Specifically, the facility did not identify a diagnosed specific condition for the treatment of a resident receiving psychotropic medications, which is a requirement under §483.45(e)(1)-(5). Resident R62, who was admitted to the facility on 9/1/21, was receiving psychotropic medications without a documented specific condition for treatment. The resident's clinical record indicated diagnoses of high blood pressure, hyperlipidemia, and dementia. However, physician orders for Seroquel and trazodone, dated 11/14/24 and 11/24/24 respectively, did not specify a condition for their use. The Director of Nursing confirmed the facility's failure to document a diagnosed specific condition for the psychotropic medication usage for Resident R62, as required by the facility's policy and regulatory standards.

Plan Of Correction

Resident #62 no longer resides at the facility. To identify other residents that have the potential to be affected, the DON/designee reviewed current residents on psychotropic medications to ensure resident medication regimens are free from unnecessary medications and that there is a diagnosed specific condition for treatment. Corrections will be made as needed. To prevent this from recurring, the RDCS/designee educated DON, ADON and pharmacy consultant on the regulatory requirements of F758 on ensuring resident medication regimens are free from unnecessary medications, and that there is a diagnosed specific condition for treatment. To monitor and maintain ongoing compliance, the DON/designee will review the medical record of 3 residents on psychotropic medications weekly x4 then monthly x2 to ensure that there is a diagnosed specific condition for treatment regarding medication. Negative findings will be addressed. Ad Hoc education will be provided as needed. The results of the audits will be forwarded to the facility Quality Assurance Performance Improvement (QAPI) committee for further review and recommendations.

An unhandled error has occurred. Reload 🗙